维多利亚-黑尔 医药企业家

shiyi18

Victoria Hale
Pharmaceutical Entrepreneur | Class of 2006
Navigating regulatory processes to develop affordable drugs for neglected diseases and to deliver them around the world to those most in need.

Portrait of Victoria Hale
Photos for download >
Title
Pharmaceutical Entrepreneur
Affiliation
Institute for OneWorld Health
Location
San Francisco, California
Age
45 at time of award
Area of Focus
Health Care Delivery
Published September 1, 2006
ABOUT VICTORIA'S WORK
Victoria Hale is a pharmaceutical chemist who combined individual entrepreneurship and social vision to found the Institute for OneWorld Health (iOWH), a nonprofit pharmaceutical company with a mission to develop affordable drugs for neglected diseases that plague the world’s poorest populations. Applying years of experience as both an FDA official and a pharmaceutical executive, she created a model for drug development that is driven by the needs of the developing world. iOWH’s expertise extends from identifying drug and vaccine leads, to conducting extensive clinical trials, to securing regulatory approval for new medicines. Focusing on potential cures for parasite-borne diseases, Hale and her colleagues acquire donated rights to promising compounds that have either been deemed unprofitable by the pharmaceutical industry or left undeveloped by research labs unable to obtain funding. Since its inception in 2000, Hale’s institute has collaborated with universities, hospitals, drug manufacturers, and international regulatory agencies and marshaled significant financial resources from foundations, corporations, and individuals to launch five drug and vaccine development programs that span four neglected disease areas and three continents. iOWH recently received approval for and brought to market its first drug, paromomycin, a low-cost antibiotic cure for visceral leishmaniasis, which afflicts approximately 1.5 million people worldwide, primarily in India, Nepal, Bangladesh, and Sudan. Treatments underway for malaria, diarrheal disease, and Chagas disease hold the potential to save the lives of millions more. By negotiating regulatory processes that have long stymied drug delivery to those most in need, Hale is scaling what many have viewed as an indomitable wall and working to relieve human suffering on a massive, global scale.

BIOGRAPHY
Victoria Hale received a B.S. (1983) in pharmacy from the University of Maryland and a Ph.D. (1990) in pharmaceutical chemistry from the University of California, San Francisco. Prior to founding the Institute for OneWorld Health in 2000, she served as chief scientific officer and co-founder of Axiom Biomedical, Inc. (1999-2000), as a scientist at Genentech, Inc. (1994-1997), and as a senior reviewer for the U.S. Food and Drug Administration (1990-1994). Since 2002, she has also been an adjunct associate professor of biopharmaceutical sciences at the University of California, San Francisco.



维多利亚-黑尔
医药企业家|2006级
驾驭监管程序，为被忽视的疾病开发可负担得起的药物，并将其提供给世界各地最需要的人。

维多利亚-黑尔的画像
图片下载 >
标题
制药企业家
工作单位
单一世界健康研究所
工作地点
加州旧金山市
年龄
获奖时45岁
重点领域
医疗保健服务
发表于2006年9月1日
关于维多利亚的工作
维多利亚-黑尔是一位制药化学家，她将个人创业精神和社会愿景结合起来，创立了 "世界健康研究所"（iOWH），这是一家非营利性制药公司，其使命是为困扰世界最贫困人口的被忽视的疾病开发价格低廉的药物。她运用多年来作为美国食品和药物管理局官员和制药业高管的经验，创建了一个以发展中国家的需求为动力的药物开发模式。iOWH的专业技能包括识别药物和疫苗线索，进行广泛的临床试验，以及确保新药的监管批准。Hale和她的同事们专注于寄生虫传播疾病的潜在治疗方法，他们获得了有希望的化合物的捐赠权，这些化合物要么被制药业认为无利可图，要么被无法获得资金的研究实验室搁置不开发。自2000年成立以来，黑尔的研究所已经与大学、医院、药品制造商和国际监管机构合作，并从基金会、公司和个人那里调集了大量财政资源，启动了五个药物和疫苗开发项目，涉及四个被忽视的疾病领域和三个大陆。正在进行的对疟疾、腹泻病和南美锥虫病的治疗，有可能拯救更多的人的生命。通过与长期以来阻碍向最需要的人提供药物的监管程序进行谈判，海尔正在翻越许多人认为是不屈不挠的墙，努力在全球范围内减轻人类的痛苦。

个人简历
维多利亚-黑尔在马里兰大学获得药学学士学位（1983年），并在加利福尼亚大学旧金山分校获得药物化学博士学位（1990年）。在2000年成立世界健康研究所之前，她曾担任Axiom生物医学公司的首席科学官和共同创始人（1999-2000年），在Genentech公司担任科学家（1994-1997年），并担任美国食品和药物管理局的高级审查员（1990-1994年）。自2002年起，她还担任了加州大学旧金山分校生物制药科学的兼职副教授。